Provided by Tiger Trade Technology Pte. Ltd.

Apogee Therapeutics

134.76
+0.01000.01%
Volume:530.67K
Turnover:71.51M
Market Cap:10.15B
PE:-31.05
High:134.81
Open:134.79
Low:134.71
Close:134.75
52wk High:134.88
52wk Low:35.39
Shares:75.34M
Float Shares:58.14M
Volume Ratio:0.52
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3400
EPS(LYR):-4.2155
ROE:-32.46%
ROA:-20.30%
PB:8.50
PE(LYR):-31.97

Loading ...

AbbVie would gain an experimental eczema drug by buying biotech: report

Dow Jones
·
Jun 21

M&A News: AbbVie Lining up an $11B Deal for Eczema Drug Maker Apogee Therapeutics

TIPRANKS
·
Jun 20

Apogee Therapeutics Shareholders Back Board, Auditors, Compensation

TIPRANKS
·
Jun 13

Apogee Therapeutics CEO Michael Thomas Henderson sells USD 1.65 million in common shares

Reuters
·
Jun 13

Apogee Therapeutics shareholders elect Class III directors at annual meeting

Reuters
·
Jun 13

Analysts’ Top Healthcare Picks: Aveanna Healthcare Holdings (AVAH), Apogee Therapeutics (APGE)

TIPRANKS
·
Jun 12

Apogee Shares Close to Reflect Atopic Dermatitis Prospects, RBC Says

MT Newswires Live
·
Jun 08

Apogee Therapeutics Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Jun 08

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (APGE), Inventiva (IVA) and Roche Holding AG (OtherRHHVF)

TIPRANKS
·
Jun 08

RBC Raises Price Target on Apogee Therapeutics to $97 From $82, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
Jun 08

Apogee Therapeutics Inc : RBC Raises Target Price to $97 From $82

THOMSON REUTERS
·
Jun 08

U.S. RESEARCH ROUNDUP- Adobe, Allstate, Teleflex

Reuters
·
Jun 08

Apogee Therapeutics CMO Carl Dambkowski sells 5,500 common shares for $432,905

Reuters
·
Jun 06

Deutsche Bank Adjusts PT on Apogee Therapeutics to $116 From $118, Maintains Buy Rating

MT Newswires Live
·
Jun 03

Apogee Therapeutics to Participate in Upcoming June Conferences

GlobeNewswire
·
May 29

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Apogee Therapeutics (APGE) and Align Tech (ALGN)

TIPRANKS
·
May 28

Apogee Therapeutics moved to Neutral at Goldman Sachs

TIPRANKS
·
May 28

Canaccord Genuity Sticks to Its Buy Rating for Apogee Therapeutics (APGE)

TIPRANKS
·
May 28

U.S. RESEARCH ROUNDUP-Salesforce, Snowflake, Zscaler

Reuters
·
May 28

Apogee Therapeutics Inc : Stephens Raises Target Price to $115 From $110

THOMSON REUTERS
·
May 28